Skip to main content
Equibles

HRT FINANCIAL LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1475597 NEW YORK, NY
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,311,203
+$4,456,110 QoQ
Shares Held
209,929
+423.9% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 354 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. ACAD ranks #39 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in ACAD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,311,203 209,929
2025-09-30 $855,093 40,070
2024-12-31 $1,705,192 92,926
2024-09-30 $805,419 52,368
2024-06-30 $2,857,058 175,819
2024-03-31 $629,824 34,063
2023-12-31 $9,723,696 310,562
2023-09-30 $612,633 29,397
2023-03-31 $4,841,200 257,237
2022-06-30 $787,884 55,918
2022-03-31 $1,014,769 41,898
2021-12-31 $3,137,572 134,429
2020-09-30 $2,691,933 65,259
2020-06-30 $4,614,683 95,207